Search Results | Cancer Research | American Association for Cancer Research

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Abstract 1994: Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells

Kevin Brasseur, Pascal Adam, Laurence Tardif, François Fabi, Sophie Parent, Éric Asselin

Cancer Res (2016) 76 (14_Supplement): 1994.

DOI: https://doi.org/10.1158/1538-7445.AM2016-1994

Published: 15 July 2016

View article

Journal Articles

Abstract 2111: Regulation and localization of the cleaved form of PAR-4 in ovarian and endometrial cancers

Kevin Brasseur, Valérie Leblanc, Sophie Parent, Éric Asselin

Cancer Res (2015) 75 (15_Supplement): 2111.

DOI: https://doi.org/10.1158/1538-7445.AM2015-2111

Published: 01 August 2015

View article

Journal Articles

Abstract 1958: Interaction between keratin intermediate filament proteins K8/18 and cancer related signal transduction proteins in epithelial cells

Stephanie Lamontagne, Anne-Marie Fortier, Sophie Parent, Eric Asselin, Monique Cadrin

Cancer Res (2015) 75 (15_Supplement): 1958.

DOI: https://doi.org/10.1158/1538-7445.AM2015-1958

Published: 01 August 2015

View article

Journal Articles

Abstract 3810: Leptomycin B sensitizes ovarian and endometrial cancer cells to TRAIL-induced apoptosis

François Fabi, France-Hélène Joncas, Sophie Parent, Valérie Leblanc, Eric Asselin

Cancer Res (2015) 75 (15_Supplement): 3810.

DOI: https://doi.org/10.1158/1538-7445.AM2015-3810

Published: 01 August 2015

View article

Journal Articles

Abstract 3386: Post-translational mechanisms related to PAR-4 regulation in endometrial cancer

Kevin Brasseur, Sophie Parent, François Fabi, Éric Asselin

Cancer Res (2014) 74 (19_Supplement): 3386.

DOI: https://doi.org/10.1158/1538-7445.AM2014-3386

Published: 01 October 2014

View article

Journal Articles

Abstract 3347: Post-translational modifications of Akt isoform in chemoresistance of endometrial cancer

Jérôme Grenier-Naud, Sophie Parent, Eric Asselin

Cancer Res (2014) 74 (19_Supplement): 3347.

DOI: https://doi.org/10.1158/1538-7445.AM2014-3347

Published: 01 October 2014

View article

Journal Articles

Abstract 824: Regulation of PAR-4 activity in chemoresistant ovarian cancer cells: A major role for the cleaved fragment in the control of apoptosis.

Kevin Brasseur, Sophie Parent, Éric Asselin

Cancer Res (2013) 73 (8_Supplement): 824.

DOI: https://doi.org/10.1158/1538-7445.AM2013-824

Published: 15 April 2013

View article

Journal Articles

Abstract 293: TGF-b regulates Par-4 expression through XIAP in ovarian and endometrial cancers.

Francois Fabi, Sophie Parent, Valérie Leblanc, Eric Asselin

Cancer Res (2013) 73 (8_Supplement): 293.

DOI: https://doi.org/10.1158/1538-7445.AM2013-293

Published: 15 April 2013

View article

Journal Articles

Abstract 4889: ERa-targeted therapy in ovarian cancer cells using novel Estradiol-Platinum(II) hybrids

Kevin Brasseur, Valérie Leblanc, Céline Van Themsche, Sophie Parent, Caroline Descoteaux, Gervais Bérubé, Éric Asselin

Cancer Res (2012) 72 (8_Supplement): 4889.

DOI: https://doi.org/10.1158/1538-7445.AM2012-4889

Published: 15 April 2012

View article

Journal Articles

Abstract 3995: C-terminal fragment of prostate apoptosis response-4 (Par-4) generated by caspase-3 cleavage induces apoptosis in cancer cells

Parvesh Chaudhry, Mohan Singh, Sophie Parent, Eric Asselin

Cancer Res (2012) 72 (8_Supplement): 3995.

DOI: https://doi.org/10.1158/1538-7445.AM2012-3995

Published: 15 April 2012

View article

Journal Articles

Abstract 2516: ERa-targeted therapy in ovarian cancer cells by 17b-estradiol-linked chemotherapeutic hybrid; VP-128 (E2-Pt(II))

Kevin Brasseur, Valérie Leblanc, Sophie Parent, Caroline Descôteaux, Gervais Bérubé, Éric Asselin, Molecular oncology and endocrinology group

Cancer Res (2011) 71 (8_Supplement): 2516.

DOI: https://doi.org/10.1158/1538-7445.AM2011-2516

Published: 15 April 2011

View article

Journal Articles

Abstract 1035: Bcl2 is regulated by PKC and Akt and is associated with resistance to cisplatin in endometrial cancer cells.

Alexandre Rouette, Julie Girouard, Valérie Leblanc, Sophie Parent, Éric Asselin

Cancer Res (2010) 70 (8_Supplement): 1035.

DOI: https://doi.org/10.1158/1538-7445.AM10-1035

Published: 15 April 2010

View article

Journal Articles

Abstract 4467: Differential response of ERa-targeted therapy in breast and ovarian cancer cells by 17b-estradiol-linked platinum(II) hybrid (E₂-Pt(II)), VP-128

Sophie Parent, Céline Van Themsche, Valérie Leblanc, Caroline Descôteaux, Josée Provencher-Mandeville, Geoffroy Bélanger, Gervais Bérubé, Eric Asselin

Cancer Res (2010) 70 (8_Supplement): 4467.

DOI: https://doi.org/10.1158/1538-7445.AM10-4467

Published: 15 April 2010

View article

Journal Articles

Abstract 743: Assessment of novel tyrosine-chlorambucil hybrid molecules on a panel of breast, ovarian, and uterine cancer cell lines

Valerie Leblanc, Caroline Descoteaux, Sophie Parent, Gervais Berube, Eric Asselin

Cancer Res (2010) 70 (8_Supplement): 743.

DOI: https://doi.org/10.1158/1538-7445.AM10-743

Published: 15 April 2010

View article

Journal Articles

DNA interaction and gene activation with new estrogen-platinum(II) compounds: A comparative study with cisplatin

Caroline Descoteaux, Christophe N'soukpoe-Kossi, Sophie Parent, Heidar-Ali Tajmir-Riahi, Eric Asselin, Gervais Berube

Cancer Res (2008) 68 (9_Supplement): 5705.

Published: 01 May 2008

View article

Journal Articles

Transforming growth factor-beta 3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent upregulation of X-linked inhibitor of apoptosis and protein kinase C-dependent induction of matrix metalloproteinase-9

Celine Van Themsche, Sophie Parent, Eric Asselin

Cancer Res (2007) 67 (9_Supplement): 3075.

Published: 01 May 2007

View article

Journal Articles

X-linked inhibitor of apoptosis protein and Akt: two anti-apoptotic proteins involved in chemoresistance of endometrial cancer cells

Steve Turner, Veronique Gagnon, Sophie Parent, Eric Asselin

Cancer Res (2007) 67 (9_Supplement): 3589.

Published: 01 May 2007

View article

Journal Articles

Development of unique estrogen-cytotoxic hybrid molecules showing affinity for the estrogen receptor and in vivo anticancer activity

Caroline Descoteaux, Josee Provencher-Mandeville, Celine Van Themsche, Valerie Leblanc, Geoffroy Belanger, Sophie Parent, Atul Gupta, Eric Asselin, Gervais Berube

Cancer Res (2007) 67 (9_Supplement): 4176.

Published: 01 May 2007

View article

Journal Articles

Effects of novel 17β-estradiol-platinum(II) complexes in ER positive and negative breast cancer cells: inhibition of cell proliferation in vitro and tumor growth in vivo

Sophie Parent, Geoffroy Belanger, Caroline Descoteaux, Celine Van Themsche, Valerie Leblanc, Gervais Berube, Eric Asselin

Cancer Res (2006) 66 (8_Supplement): 133.

Published: 15 April 2006

View article

Journal Articles

TGF-β3 upregulates XIAP and increases the invasiveness of endometrial carcinoma cells

Céline Van Themsche, Sophie Parent, Eric Asselin

Cancer Res (2006) 66 (8_Supplement): 823.

Published: 15 April 2006

View article

NARROW

Abstract 1994: Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells

Abstract 2111: Regulation and localization of the cleaved form of PAR-4 in ovarian and endometrial cancers

Abstract 1958: Interaction between keratin intermediate filament proteins K8/18 and cancer related signal transduction proteins in epithelial cells

Abstract 3810: Leptomycin B sensitizes ovarian and endometrial cancer cells to TRAIL-induced apoptosis

Abstract 3386: Post-translational mechanisms related to PAR-4 regulation in endometrial cancer

Abstract 3347: Post-translational modifications of Akt isoform in chemoresistance of endometrial cancer

Abstract 824: Regulation of PAR-4 activity in chemoresistant ovarian cancer cells: A major role for the cleaved fragment in the control of apoptosis.

Abstract 293: TGF-b regulates Par-4 expression through XIAP in ovarian and endometrial cancers.

Abstract 4889: ERa-targeted therapy in ovarian cancer cells using novel Estradiol-Platinum(II) hybrids

Abstract 3995: C-terminal fragment of prostate apoptosis response-4 (Par-4) generated by caspase-3 cleavage induces apoptosis in cancer cells

Abstract 2516: ERa-targeted therapy in ovarian cancer cells by 17b-estradiol-linked chemotherapeutic hybrid; VP-128 (E2-Pt(II))

Abstract 1035: Bcl2 is regulated by PKC and Akt and is associated with resistance to cisplatin in endometrial cancer cells.

Abstract 4467: Differential response of ERa-targeted therapy in breast and ovarian cancer cells by 17b-estradiol-linked platinum(II) hybrid (E₂-Pt(II)), VP-128

Abstract 743: Assessment of novel tyrosine-chlorambucil hybrid molecules on a panel of breast, ovarian, and uterine cancer cell lines

DNA interaction and gene activation with new estrogen-platinum(II) compounds: A comparative study with cisplatin

Transforming growth factor-beta 3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent upregulation of X-linked inhibitor of apoptosis and protein kinase C-dependent induction of matrix metalloproteinase-9

X-linked inhibitor of apoptosis protein and Akt: two anti-apoptotic proteins involved in chemoresistance of endometrial cancer cells

Development of unique estrogen-cytotoxic hybrid molecules showing affinity for the estrogen receptor and in vivo anticancer activity

Effects of novel 17β-estradiol-platinum(II) complexes in ER positive and negative breast cancer cells: inhibition of cell proliferation in vitro and tumor growth in vivo

TGF-β3 upregulates XIAP and increases the invasiveness of endometrial carcinoma cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only